NEW YORK (GenomeWeb) – Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission.

The deal creates a science sector giant that will "cover every step of the biotech production chain," Merck said in a statement. The company will have around 50,000 employees in 67 countries, working at 72 manufacturing sites worldwide, with combined pro forma full-year life science sales of €4.6 billion in 2014 and expected sales between €12.6 billion and €12.8 billion in 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.